Interpr8 builds AI‑driven, multi‑modal data products for life‑science companies, enabling them to extract insights from text, images, and numerical datasets. Their platform combines NLP, computer‑vision, and statistical modeling to deliver rigorous, fast‑acting solutions such as AI product management tools and go‑to‑market planning. By unifying disparate data sources, Interpr8 helps life‑science teams accelerate research and decision‑making across the drug development pipeline.
Funding
Funding not disclosed
Founders
Product
Problem
Life‑science companies often have valuable data scattered across text documents, images, and numerical tables, making it difficult to integrate and analyze these heterogeneous sources quickly and reliably.
Solution
Interpr8 offers AI‑driven data products that combine natural language processing, computer vision, and statistical modeling to extract and unify insights from textual, graphical, and numerical data. Their multi‑modal platform processes diverse data types, applies rigorous validation, and delivers fast analytics that support research, drug development, and go‑to‑market planning. By delivering integrated, statistically relevant results, Interpr8 enables life‑science teams to accelerate discovery and make informed decisions throughout the product lifecycle.
Target Audience
Primary customers are pharmaceutical, biotechnology, and medical‑device companies that need integrated analytics across research, development, and market‑access functions.
Features
- Multi‑modal AI pipelines that ingest and analyze text, images, and structured data in a single workflow
- Natural language processing models tuned for scientific literature, regulatory documents, and clinical reports
- Computer‑vision algorithms for extracting information from figures, microscopy images, and assay readouts
- Statistical modeling layer that validates findings and quantifies uncertainty for regulatory compliance
- Customizable data products that can be embedded into existing research and development pipelines
- Rapid turnaround times through automated, scalable cloud‑based processing